Thailand Legal Cannabis Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

Thailand's legal cannabis market encompasses medical cannabis products, CBD-dominated wellness and food supplement products, and industrial hemp applications for textiles, construction materials, and biofuels. Following the landmark 2022 decriminalization that removed cannabis and hemp from the country's narcotics schedule, the market opened to licensed cultivators, processors, and retailers, creating a formal regulatory framework that replaced a previously unregulated gray market. The market's valuation of USD 1.31 billion in 2024 reflects early-stage commercialization across licensed dispensaries, hospitals, and wellness retail channels, with significant room for expansion as regulatory clarity improves and international export pathways develop.

• •Market valued at USD 1.31 billion in 2024, projected to reach USD 7.10 billion by 2030 at 23.5% CAGR
• •Thailand became the first Southeast Asian country to decriminalize cannabis in June 2022, removing it from the narcotics list
• •Asia Pacific legal cannabis market estimated at USD 36.2 billion in 2025, projected to reach USD 345.7 billion by 2035

Medical tourism is a primary catalyst, as Thailand's world-renowned healthcare infrastructure attracts millions of international patients annually, many seeking cannabinoid-based treatments that remain unavailable or heavily restricted in their home countries. Domestically, surging consumer interest in CBD wellness products, including oils, edibles, and topicals, has expanded the addressable market beyond medical applications into the broader health and lifestyle segment. Government support for licensed hemp cultivation, including tax incentives and agricultural zoning, has encouraged farmers to transition from traditional crops to high-value cannabis and hemp production.

• •CBD products are dominating revenue shares in Thailand's legal cannabis market, driven by wellness and medical demand
• •Thailand's established medical tourism infrastructure, drawing over 3 million international health tourists annually, creates a built-in patient base for medical cannabis
• •Agricultural policy reforms and government-backed hemp licensing programs have incentivized large-scale cultivation across rural provinces

The market splits into medical cannabis (prescribed treatments for conditions including chronic pain, epilepsy, and chemotherapy side effects) and non-medical CBD products (wellness supplements, cosmetics, and food products), with CBD-dominant formulations representing the largest revenue segment. Industrial hemp for fiber, seed, and construction materials is a smaller but emerging category gaining regulatory attention. Geographically, Bangkok and central Thailand constitute the primary commercial hub, while northern provinces such as Chiang Mai and Chiang Rai have emerged as cultivation centers due to favorable climate conditions, and southern tourist regions drive wellness-oriented demand.

• •CBD-dominant products dominate revenue, while THC-dominant formulations remain tightly restricted to licensed medical settings
• •Bangkok and central Thailand serve as the primary commercial and distribution hub; northern provinces lead in licensed cultivation acreage
• •Medical cannabis segments are concentrated around major hospital networks and licensed treatment centers in urban areas

Who are the notable companies in the industry?

The market remains in a relatively fragmented early stage, with no dominant integrated producers controlling the full supply chain from seed to retail. The competitive structure consists of licensed domestic cultivators, many of whom are transitioning from conventional agriculture, alongside specialty processors focused on CBD extraction and formulation, and a growing network of retail dispensaries and wellness product distributors. Production relies on a mix of outdoor cultivation suited to Thailand's tropical climate and controlled greenhouse operations for higher-value medical-grade output, with cold-press extraction being the dominant technology for CBD oil production and CO2 extraction gaining traction among premium processors.

• •Market is fragmented with many small-to-mid-sized licensed operators; no single entity commands a dominant national share
• •Supply chain is partially integrated, most cultivators do not control downstream processing or retail, and most retailers rely on multiple supplier relationships
• •Production concentrated in northern ( Chiang Mai, Chiang Rai ) and northeastern ( Khon Kaen, Loei ) agricultural zones where climate and soil conditions favor outdoor and greenhouse cultivation

What are the recent trends and outlook?

The market is moving toward greater regulatory formalization, with the government expected to tighten THC potency thresholds, strengthen licensing requirements, and establish clearer export frameworks, steps that will separate compliant operators from informal market participants. Medical cannabis exports represent a significant long-term opportunity, as Thailand positions itself as a regional hub supplying Southeast Asian and Middle Eastern markets where domestic production remains limited. Wellness product innovation, including CBD-infused beverages, cosmetics, and functional foods, is expected to drive consumer market growth over the forecast period, supported by rising health consciousness across Southeast Asian urban populations.

• •Regulatory tightening around THC limits and licensing standards will consolidate the market, favoring well-capitalized and compliant operators
• •Export-oriented production is emerging as a strategic priority, with Thailand seeking to supply medical cannabis to regional markets with restricted domestic capacity
• •CBD-infused consumer products, beverages, cosmetics, and nutraceuticals, are expected to outpace traditional medical cannabis revenue growth through 2030